These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6328950)

  • 1. Antisecretagogues and parietal cells.
    Sewing KF
    Agents Actions; 1984 Apr; 14(3-4):319-24. PubMed ID: 6328950
    [No Abstract]   [Full Text] [Related]  

  • 2. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological agents of gastric acid secretion: receptor antagonists and pump inhibitors.
    Wallmark B; Fryklund J
    Methods Enzymol; 1990; 191():721-38. PubMed ID: 1963658
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
    Nagaya H; Inatomi N; Nohara A; Satoh H
    Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
    Lamers CB
    Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuing development of acid pump inhibitors: site of action of pantoprazole.
    Shin JM; Besancon M; Prinz C; Simon A; Sachs G
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of the gastric acid secretion inhibitor omeprazole.
    Lindberg P; Nordberg P; Alminger T; Brändström A; Wallmark B
    J Med Chem; 1986 Aug; 29(8):1327-9. PubMed ID: 3016260
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
    Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
    Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of substituted benzimidazoles on acid secretion in isolated and enriched guinea pig parietal cells.
    Sewing KF; Harms P; Schulz G; Hannemann H
    Gut; 1983 Jun; 24(6):557-60. PubMed ID: 6303916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sulphoxide moiety of substituted benzimidazoles is essential for inhibition of parietal cell K+/H+-ATPase.
    Beil W; Eltze M; Heintze K; Klemm K; Riedel R; Schudt C; Sewing KF; Simon A
    Br J Pharmacol; 1986 Jun; 88(2):389-95. PubMed ID: 3015311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.
    Sanfilippo PJ; Urbanski M; Press JB; Hajos ZG; Shriver DA; Scott CK
    J Med Chem; 1988 Sep; 31(9):1778-85. PubMed ID: 2842503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)].
    Kawai T; Ikeda H; Harada Y; Saitou T
    Nihon Rinsho; 1992 Jan; 50(1):188-93. PubMed ID: 1311785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
    Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
    Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of H+,K+-ATPase by methyl(E)-2-(3,4-dimethoxystyryl)-benzimidazole-4-carboxylate (ALE-36).
    Yamamoto O; Tanaka H; Ueda F; Kimura K
    Scand J Gastroenterol Suppl; 1989; 162():178-81. PubMed ID: 2556788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New fluorescent probes E3810 and methoxy E3810 for determining distributions of the apical membrane and the acidic compartment of gastric acid secreting cells.
    Takeguchi N; Yamanouchi T; Sakai H; Morii M
    Jpn J Physiol; 1992; 42(1):75-88. PubMed ID: 1320706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole: mode of action and effect on acid secretion in animals.
    Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():12-8. PubMed ID: 2557668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are proton pump inhibitors safe?].
    Creutzfeldt W
    Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.